MARKET INTRODUCTION
The patient of latent TB does not show any kind of symptoms even when they are infected by M. tuberculosis. Also, the person suffering from latent TB does not spread the disease. Majorly, tuberculin skin test or TB blood test are recommended for the diagnosis of latent TB infection.
MARKET DYNAMICS
The Latent Tuberculosis Infection Testing Market is driving due to increasing prevalence of latent TB and introduction of new product launches. However, lack of disease awareness in emerging nations to hamper the growth of the global Latent Tuberculosis Infection Testing Market.
MARKET SCOPE
The "Latent Tuberculosis Infection Testing Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Latent Tuberculosis Infection Testing Market with detailed market segmentation by type and application. The Latent Tuberculosis Infection Testing Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Latent Tuberculosis Infection Testing Market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Latent Tuberculosis Infection Testing Market is segmented on the basis of type and end user. Based on type, the market is segmented as tuberculin skin test (TST), interferon gamma released assay (IGRA), and other types. On the basis of application, the market is segmented as Household Contacts with Pulmonary TB, PLHIV, and other applications.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Latent Tuberculosis Infection Testing Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Latent Tuberculosis Infection Testing Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Latent Tuberculosis Infection Testing Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Latent Tuberculosis Infection Testing Market in these regions.
MARKET PLAYERS
The report covers key developments in the Latent Tuberculosis Infection Testing Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Latent Tuberculosis Infection Testing Market are anticipated to have lucrative growth opportunities in the future with the rising demand for smart hospital beds in the global market. Below mentioned is the list of few companies engaged in the Latent Tuberculosis Infection Testing Market.
The report also includes the profiles of key players in Latent Tuberculosis Infection Testing Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Danaher
- BD
- Abbott
- F. Hoffmann-La Roche Ltd
- Bio-Rad Laboratories, Inc.
- Agilent Technologies, Inc.
- Thermo Fisher Scientific
- Eppendorf
- bioM?rieux SA
- QIAGEN
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. PUBLISHER RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
 1.3.1 Latent Tuberculosis Infection (LTBI) Testing Market - By Type
 1.3.2 Latent Tuberculosis Infection (LTBI) Testing Market - By Application
 1.3.3 Latent Tuberculosis Infection (LTBI) Testing Market - By Region
 1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. LATENT TUBERCULOSIS INFECTION (LTBI) TESTING MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
 4.2.1 North America - Pest Analysis
 4.2.2 Europe - Pest Analysis
 4.2.3 Asia-Pacific - Pest Analysis
 4.2.4 Middle East and Africa - Pest Analysis
 4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. LATENT TUBERCULOSIS INFECTION (LTBI) TESTING MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. LATENT TUBERCULOSIS INFECTION (LTBI) TESTING MARKET - GLOBAL MARKET ANALYSIS
6.1. LATENT TUBERCULOSIS INFECTION (LTBI) TESTING - GLOBAL MARKET OVERVIEW
6.2. LATENT TUBERCULOSIS INFECTION (LTBI) TESTING - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. LATENT TUBERCULOSIS INFECTION (LTBI) TESTING MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. TUBERCULIN SKIN TEST (TST)
 7.3.1. Overview
 7.3.2. Tuberculin Skin Test (TST) Market Forecast and Analysis
7.4. INTERFERON GAMMA RELEASED ASSAY (IGRA)
 7.4.1. Overview
 7.4.2. Interferon Gamma Released Assay (IGRA) Market Forecast and Analysis
7.5. OTHER TYPES
 7.5.1. Overview
 7.5.2. Other Types Market Forecast and Analysis
8. LATENT TUBERCULOSIS INFECTION (LTBI) TESTING MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. HOUSEHOLD CONTACTS WITH PULMONARY TB
 8.3.1. Overview
 8.3.2. Household Contacts with Pulmonary TB Market Forecast and Analysis
8.4. PLHIV
 8.4.1. Overview
 8.4.2. PLHIV Market Forecast and Analysis
8.5. OTHER APPLICATIONS
 8.5.1. Overview
 8.5.2. Other Applications Market Forecast and Analysis
9. LATENT TUBERCULOSIS INFECTION (LTBI) TESTING MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
 9.1.1 North America Latent Tuberculosis Infection (LTBI) Testing Market Overview
 9.1.2 North America Latent Tuberculosis Infection (LTBI) Testing Market Forecasts and Analysis
 9.1.3 North America Latent Tuberculosis Infection (LTBI) Testing Market Forecasts and Analysis - By Type
 9.1.4 North America Latent Tuberculosis Infection (LTBI) Testing Market Forecasts and Analysis - By Application
 9.1.5 North America Latent Tuberculosis Infection (LTBI) Testing Market Forecasts and Analysis - By Countries
 9.1.5.1 United States Latent Tuberculosis Infection (LTBI) Testing Market
 9.1.5.1.1 United States Latent Tuberculosis Infection (LTBI) Testing Market by Type
 9.1.5.1.2 United States Latent Tuberculosis Infection (LTBI) Testing Market by Application
 9.1.5.2 Canada Latent Tuberculosis Infection (LTBI) Testing Market
 9.1.5.2.1 Canada Latent Tuberculosis Infection (LTBI) Testing Market by Type
 9.1.5.2.2 Canada Latent Tuberculosis Infection (LTBI) Testing Market by Application
 9.1.5.3 Mexico Latent Tuberculosis Infection (LTBI) Testing Market
 9.1.5.3.1 Mexico Latent Tuberculosis Infection (LTBI) Testing Market by Type
 9.1.5.3.2 Mexico Latent Tuberculosis Infection (LTBI) Testing Market by Application
9.2. EUROPE
 9.2.1 Europe Latent Tuberculosis Infection (LTBI) Testing Market Overview
 9.2.2 Europe Latent Tuberculosis Infection (LTBI) Testing Market Forecasts and Analysis
 9.2.3 Europe Latent Tuberculosis Infection (LTBI) Testing Market Forecasts and Analysis - By Type
 9.2.4 Europe Latent Tuberculosis Infection (LTBI) Testing Market Forecasts and Analysis - By Application
 9.2.5 Europe Latent Tuberculosis Infection (LTBI) Testing Market Forecasts and Analysis - By Countries
 9.2.5.1 Germany Latent Tuberculosis Infection (LTBI) Testing Market
 9.2.5.1.1 Germany Latent Tuberculosis Infection (LTBI) Testing Market by Type
 9.2.5.1.2 Germany Latent Tuberculosis Infection (LTBI) Testing Market by Application
 9.2.5.2 France Latent Tuberculosis Infection (LTBI) Testing Market
 9.2.5.2.1 France Latent Tuberculosis Infection (LTBI) Testing Market by Type
 9.2.5.2.2 France Latent Tuberculosis Infection (LTBI) Testing Market by Application
 9.2.5.3 Italy Latent Tuberculosis Infection (LTBI) Testing Market
 9.2.5.3.1 Italy Latent Tuberculosis Infection (LTBI) Testing Market by Type
 9.2.5.3.2 Italy Latent Tuberculosis Infection (LTBI) Testing Market by Application
 9.2.5.4 Spain Latent Tuberculosis Infection (LTBI) Testing Market
 9.2.5.4.1 Spain Latent Tuberculosis Infection (LTBI) Testing Market by Type
 9.2.5.4.2 Spain Latent Tuberculosis Infection (LTBI) Testing Market by Application
 9.2.5.5 United Kingdom Latent Tuberculosis Infection (LTBI) Testing Market
 9.2.5.5.1 United Kingdom Latent Tuberculosis Infection (LTBI) Testing Market by Type
 9.2.5.5.2 United Kingdom Latent Tuberculosis Infection (LTBI) Testing Market by Application
9.3. ASIA-PACIFIC
 9.3.1 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Overview
 9.3.2 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Forecasts and Analysis
 9.3.3 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Forecasts and Analysis - By Type
 9.3.4 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Forecasts and Analysis - By Application
 9.3.5 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Forecasts and Analysis - By Countries
 9.3.5.1 Australia Latent Tuberculosis Infection (LTBI) Testing Market
 9.3.5.1.1 Australia Latent Tuberculosis Infection (LTBI) Testing Market by Type
 9.3.5.1.2 Australia Latent Tuberculosis Infection (LTBI) Testing Market by Application
 9.3.5.2 China Latent Tuberculosis Infection (LTBI) Testing Market
 9.3.5.2.1 China Latent Tuberculosis Infection (LTBI) Testing Market by Type
 9.3.5.2.2 China Latent Tuberculosis Infection (LTBI) Testing Market by Application
 9.3.5.3 India Latent Tuberculosis Infection (LTBI) Testing Market
 9.3.5.3.1 India Latent Tuberculosis Infection (LTBI) Testing Market by Type
 9.3.5.3.2 India Latent Tuberculosis Infection (LTBI) Testing Market by Application
 9.3.5.4 Japan Latent Tuberculosis Infection (LTBI) Testing Market
 9.3.5.4.1 Japan Latent Tuberculosis Infection (LTBI) Testing Market by Type
 9.3.5.4.2 Japan Latent Tuberculosis Infection (LTBI) Testing Market by Application
 9.3.5.5 South Korea Latent Tuberculosis Infection (LTBI) Testing Market
 9.3.5.5.1 South Korea Latent Tuberculosis Infection (LTBI) Testing Market by Type
 9.3.5.5.2 South Korea Latent Tuberculosis Infection (LTBI) Testing Market by Application
9.4. MIDDLE EAST AND AFRICA
 9.4.1 Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Market Overview
 9.4.2 Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Market Forecasts and Analysis
 9.4.3 Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Market Forecasts and Analysis - By Type
 9.4.4 Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Market Forecasts and Analysis - By Application
 9.4.5 Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Market Forecasts and Analysis - By Countries
 9.4.5.1 South Africa Latent Tuberculosis Infection (LTBI) Testing Market
 9.4.5.1.1 South Africa Latent Tuberculosis Infection (LTBI) Testing Market by Type
 9.4.5.1.2 South Africa Latent Tuberculosis Infection (LTBI) Testing Market by Application
 9.4.5.2 Saudi Arabia Latent Tuberculosis Infection (LTBI) Testing Market
 9.4.5.2.1 Saudi Arabia Latent Tuberculosis Infection (LTBI) Testing Market by Type
 9.4.5.2.2 Saudi Arabia Latent Tuberculosis Infection (LTBI) Testing Market by Application
 9.4.5.3 U.A.E Latent Tuberculosis Infection (LTBI) Testing Market
 9.4.5.3.1 U.A.E Latent Tuberculosis Infection (LTBI) Testing Market by Type
 9.4.5.3.2 U.A.E Latent Tuberculosis Infection (LTBI) Testing Market by Application
9.5. SOUTH AND CENTRAL AMERICA
 9.5.1 South and Central America Latent Tuberculosis Infection (LTBI) Testing Market Overview
 9.5.2 South and Central America Latent Tuberculosis Infection (LTBI) Testing Market Forecasts and Analysis
 9.5.3 South and Central America Latent Tuberculosis Infection (LTBI) Testing Market Forecasts and Analysis - By Type
 9.5.4 South and Central America Latent Tuberculosis Infection (LTBI) Testing Market Forecasts and Analysis - By Application
 9.5.5 South and Central America Latent Tuberculosis Infection (LTBI) Testing Market Forecasts and Analysis - By Countries
 9.5.5.1 Brazil Latent Tuberculosis Infection (LTBI) Testing Market
 9.5.5.1.1 Brazil Latent Tuberculosis Infection (LTBI) Testing Market by Type
 9.5.5.1.2 Brazil Latent Tuberculosis Infection (LTBI) Testing Market by Application
 9.5.5.2 Argentina Latent Tuberculosis Infection (LTBI) Testing Market
 9.5.5.2.1 Argentina Latent Tuberculosis Infection (LTBI) Testing Market by Type
 9.5.5.2.2 Argentina Latent Tuberculosis Infection (LTBI) Testing Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL LATENT TUBERCULOSIS INFECTION (LTBI) TESTING MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. LATENT TUBERCULOSIS INFECTION (LTBI) TESTING MARKET, KEY COMPANY PROFILES
12.1. DANAHER
 12.1.1. Key Facts
 12.1.2. Business Description
 12.1.3. Products and Services
 12.1.4. Financial Overview
 12.1.5. SWOT Analysis
 12.1.6. Key Developments
12.2. BD
 12.2.1. Key Facts
 12.2.2. Business Description
 12.2.3. Products and Services
 12.2.4. Financial Overview
 12.2.5. SWOT Analysis
 12.2.6. Key Developments
12.3. ABBOTT
 12.3.1. Key Facts
 12.3.2. Business Description
 12.3.3. Products and Services
 12.3.4. Financial Overview
 12.3.5. SWOT Analysis
 12.3.6. Key Developments
12.4. F. HOFFMANN-LA ROCHE LTD
 12.4.1. Key Facts
 12.4.2. Business Description
 12.4.3. Products and Services
 12.4.4. Financial Overview
 12.4.5. SWOT Analysis
 12.4.6. Key Developments
12.5. BIO-RAD LABORATORIES, INC.
 12.5.1. Key Facts
 12.5.2. Business Description
 12.5.3. Products and Services
 12.5.4. Financial Overview
 12.5.5. SWOT Analysis
 12.5.6. Key Developments
12.6. AGILENT TECHNOLOGIES, INC.
 12.6.1. Key Facts
 12.6.2. Business Description
 12.6.3. Products and Services
 12.6.4. Financial Overview
 12.6.5. SWOT Analysis
 12.6.6. Key Developments
12.7. THERMO FISHER SCIENTIFIC
 12.7.1. Key Facts
 12.7.2. Business Description
 12.7.3. Products and Services
 12.7.4. Financial Overview
 12.7.5. SWOT Analysis
 12.7.6. Key Developments
12.8. EPPENDORF
 12.8.1. Key Facts
 12.8.2. Business Description
 12.8.3. Products and Services
 12.8.4. Financial Overview
 12.8.5. SWOT Analysis
 12.8.6. Key Developments
12.9. BIOM?RIEUX SA
 12.9.1. Key Facts
 12.9.2. Business Description
 12.9.3. Products and Services
 12.9.4. Financial Overview
 12.9.5. SWOT Analysis
 12.9.6. Key Developments
12.10. QIAGEN
 12.10.1. Key Facts
 12.10.2. Business Description
 12.10.3. Products and Services
 12.10.4. Financial Overview
 12.10.5. SWOT Analysis
 12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT PUBLISHER
13.2. GLOSSARY OF TERMS
LIST OF TABLES
LIST OF FIGURES
The List of Companies
1. Danaher
2. BD
3. Abbott
4. F. Hoffmann-La Roche Ltd
5. Bio-Rad Laboratories, Inc.
6. Agilent Technologies, Inc.
7. Thermo Fisher Scientific
8. Eppendorf
9. bioM?rieux SA
10. QIAGEN